Seeking Alpha
31 Oct 2026, 09:07 UTC · 3h ago
Unicycive Therapeutics: 95% Upside Priced Against A Wall Of Dilution And Regulatory Risk
Impact · against what's priced in
UNCY is a high-risk binary play centered on the March 25, 2027 PDUFA date. While the fair value estimate suggests significant upside, the potential for a 100% increase in share count to fund commercialization acts as a major ceiling on the current valuation.
- UNCY+0.20
No priced-in read yet





